Posted: January 15, 2013 at 6:44 pm
#32 - Tissue Repair - Stem cells, the cell cycle overview, (G1, S, G2, mitosis phases)
To understand physiologic cell proliferation (as in repair) and pathologic proliferation (as in cancer), it is important to learn about the cell cycle and its regulation.
By: Kevin Mangum
Continue reading here:
#32 - Tissue Repair - Stem cells, the cell cycle overview, (G1, S, G2, mitosis phases) - Video
Posted: January 15, 2013 at 6:44 pm
#33 - Tissue regeneration, stem cells, regenerative medicine
The ability of tissues to repair themselves is influenced by their capacity to regenerate the missing tissue and their ability that is inherent for them to divide and undergo mitosis. In most continuously dividing tissues the mature cells are terminally differentiated and short-lived. As mature cells die the tissue is replenished by the differentiation of cells generated from stem cells. Thus, in these tissues there is a homeostatic equilibrium between the replication and differentiation of stem cells and the death of the mature, fully differentiated cells. Regenerative medicine is the "process of replacing or regenerating human cells, tissues or organs to restore or establish normal function".
By: Kevin Mangum
See more here:
#33 - Tissue regeneration, stem cells, regenerative medicine - Video
Posted: January 15, 2013 at 6:44 pm
UI Blood Marrow Patient Story
Throughout Jonathan Alfaro #39;s long journey of treatment for his acute leukemia, he was surrounded by a support system at the University of Illinois Hospital Health Sciences System. "They didn #39;t just tend to me as a patient, they learned about me as a person." BMT doctors helped Jonathan beat his leukemia with a stem cell transplant. After a year of remission and several relapses, umbilical-cord stem cells offered this young man a victory over a disease that threatened his life.
By: UIHospital
Read the original:
UI Blood
Posted: January 15, 2013 at 6:44 pm
Stem cells improve function in mouse model of Lou Gehrig #39;s disease
From Italy -- A new report presented at the annual meeting for the American Academy of Neurology finds that stem cells may have potential in treating amyotrophic lateral sclerosis (ALS). Researchers studied an animal model of ALS (also known as Lou Gehrig #39;s disease), injecting the rodents with neural stem cells taken from a human. Results showed that the stem cells migrated to the spinal cord and successfully multiplied. As a result, the mice had a significantly extended lifespan and a 15% improvement in their neuromuscular function.
By: insidermedicine
Read more from the original source:
Stem cells improve function in mouse model of Lou Gehrig's disease - Video
Posted: January 15, 2013 at 6:44 pm
Dr. Rob Dickerman uses patient #39;s own stem cells to heal back pain
Video from Channel 8 news in Dallas.
By: actional86
See the original post here:
Dr. Rob Dickerman uses patient's own stem cells to heal back pain - Video
Posted: January 15, 2013 at 6:44 pm
Interview with Dr Nathan Newman
Dr Nathan Newman, innovator of the stem cell lift procedure, speaks candidly about his innovation of the procedure 12 years ago, Dr Newman has performed over 1000 stem cell lifts and made many modifications and advances over the years based on clinical data and improvements in technology. He was one of the first doctors in the world to employ stem cell technology for rejuvenation. In this interview Dr Newman addresses a published report of problems with the stem cell lift in a particular case with another doctor. Dr Newman explains that the other doctor used artificial calcium fillers with the stem cells that were directly responsible for the patient developing bone fragments. Dr Newman, however, uses the body #39;s own fat as a natural filler which directs the stem cells to create normal healthy tissue without complications.
By: nathannewmanmd
Original post:
Interview with Dr Nathan Newman - Video
Posted: January 15, 2013 at 6:44 pm
Bladder Cancer Q A -- Sloan-Kettering
Memorial Sloan-Kettering bladder cancer experts answer questions about bladder cancer treatment, including the use of adult stem cells to reconstruct the urinary tract; chemotherapy for bladder cancer that has metastasized (spread); and nerve-sparing surgery to prevent erectile dysfunction. Researchers are applying genetic advances to individualize treatment for bladder cancer patients and develop targeted therapies for the disease. Early identification of bladder cancer and accurate characterization of a tumor are important for selecting the most-appropriate treatment.
By: mskcc
Continue reading here:
Bladder Cancer Q
Posted: January 15, 2013 at 6:44 pm
Stem Cell Research News Project
description
By: TheFixFactor
Follow this link:
Stem Cell Research News Project - Video
Posted: January 15, 2013 at 10:44 am
MOUNTAIN VIEW, Calif., Jan. 14, 2013 /PRNewswire/ --SanBio Inc. today announced the successful enrollment of the second dose cohort of patients in its Phase 1/2a clinical trial testing the safety and efficacy of a novel allogeneic stem cell therapy product, SB623, in patients suffering from chronic deficits resulting from previous stroke injuries. The first 12 patients, of a planned total of 18, have been successfully administered SB623. The trial is being conducted at Stanford University, the University of Pittsburgh and Northwestern University. No safety concerns have been attributed to the cell therapy product. For details regarding this clinical trial, please refer to http://www.strokeclinicaltrial.org.
SB623 is derived from adult bone marrow and has shown safety and efficacy in rodent models of chronic stroke. "The successful completion of the first two dose cohorts of this pioneering clinical trial is a clear indication of the dedication and professionalism of the entire team," said Keita Mori, SanBio CEO.
SB623 is being delivered to the damaged region of the brains of patients who have suffered an ischemic stroke. Product safety is the primary focus of the study but various measurements of efficacy are also being tested.
"We are pleased with the safety findings of the study thus far," said Dr. Ernest Yankee, SanBio's Executive Vice President of Development. "We anticipate completing the enrollment of the third and final dose cohort early in the year and reporting the results shortly thereafter."
About SB623: SB623 is a proprietary cell therapy product consisting of cells derived from genetically engineered bone marrow stromal cells obtained from healthy adult donors. SB623 is administered adjacent to the area damaged by stroke and functions by producing proteins that aid the regenerative process.
About SanBio: SanBio is a privately held San Francisco Bay Area biotechnology company focused on the discovery and development of new regenerative cell therapy products.
For more information: http://www.san-bio.com
Posted: January 14, 2013 at 6:42 am
Progress with Neural Stem Cells - Drs. Hans Keirstead Paul Lu, Advocate Roman Reed
Video of the Question Answer Session following presentations by Drs. Hans Keirstead and Mark Tuszynski.
By: unite2fightparalysis
